Onset of ascites, indicated by visible abdominal swelling and one of the cardinal symptoms in ovarian cancer patients, was significantly delayed in Cxcl9+ tumour-bearing hosts compared to the Control group (median 53 vs. 39 days; P = 0.002; Fig. 1d). This evidence concerns the gene CXCL9 and ovarian carcinoma.